4-15962615-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031950.4(FGFBP2):āc.515T>Cā(p.Leu172Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,613,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_031950.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGFBP2 | NM_031950.4 | c.515T>C | p.Leu172Pro | missense_variant | 1/2 | ENST00000259989.7 | NP_114156.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGFBP2 | ENST00000259989.7 | c.515T>C | p.Leu172Pro | missense_variant | 1/2 | 1 | NM_031950.4 | ENSP00000259989 | P1 | |
FGFBP2 | ENST00000509331.1 | n.83-2004T>C | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152076Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251412Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135878
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.0000454 AC XY: 33AN XY: 727248
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152076Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.515T>C (p.L172P) alteration is located in exon 1 (coding exon 1) of the FGFBP2 gene. This alteration results from a T to C substitution at nucleotide position 515, causing the leucine (L) at amino acid position 172 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at